Abstract:Objective To investigate the role of silent information regulator 3 (Sirt3) in glioma U87 cells, and provide new targets for early diagnosis and treatment of glioma. Methods Based on the China Brain Glioma Database (CGGA) and GEPIA2 database, the expression of Sirt3 in different grades of glioma was analyzed by bioinformatics, and the protein level of Sirt3 in the adjacent and tumor samples of 6 glioma patients was further detected by Western blotting. Then, shRNA lentivirus and CRISPR/Cas9 system were used to interfere with the expression of Sirt3 in U87 cells, and TUNEL staining, PI-Annexin V double fluorescent labeling and Western blotting were used to detect the expression of apoptosis-related proteins(Bax, Cleaved-caspase3) and lysosome membrane proteins (LAMP1, LAMP2, LAMP2A), TFEB, mTOR, and other proteins. Then mTOR small molecule inhibitor, rapamycin was employed to treat Sirt3 knockdown cells, the changes in related proteins and cell apoptosis were detected. In addition, nuclear and cytoplasmic separation experiments were carried out on U87 cells before and after Sirt3 knockout, and protein change of p-TFEB was detected. Finally, the change of lysosome membrane protein after overexpression of TFEB and Sirt3 was detected in U87 cells with knocking down and out of Sirt3. Results Sirt3 was significantly highly expressed in glioma tissue, and the level was closely associated with poor survival of the glioma patients. Sirt3 knockdown significantly enhanced cell apoptosis (P < 0.01), down-regulated the expression of LAMP1, LAMP2 and LAMP2A (P < 0.01), and improved the expression of p-mTOR (P < 0.01). Additionally, Sirt3 knockout also up-regulated p-TFEB protein level in the cytoplasm fraction (P < 0.01) while, in the Sirt3 knockout U87 cells, its overexpression reserved the protein levels of LAMP1 and LAMP2 and increased the amount of lysosome. In the Sirt3 knockdown cells, overexpression of TFEB resulted in up-regulation of LAMPs proteins(P < 0.01). Conclusion Sirt3 may affect the nuclear-cytoplasmic distribution of TFEB by regulating the mTOR signaling pathway, up-regulate the expression of LAMPs, enhance the function of lysosome, and then promote the survival and malignant proliferation of glioma cells. Our study suggests that Sirt3 may be a molecular marker for clinical diagnosis and progression of glioma.

Histone Deacetylase SIRT6 Inhibits Glioma Cell Growth Through Down-Regulating NOTCH3 Expression.

S100B Suppression Alters Polarization of Infiltrating Myeloid-Derived Cells in Gliomas and Inhibits Tumor Growth.

Influence of Small Interfering RNA-mediated Inhibiting Human Runt-Related Transcription Factor 2 and Galectin-3 Gene on Proliferation and Apoptosis of Glioma Cell U251

SIRT3 Inhibits Cell Proliferation in Human Gastric Cancer Through Down-Regulation of Notch-1.

The Histone Deacetylase SIRT6 Suppresses the Expression of the RNA-binding Protein PCBP2 in Glioma

SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines.

The Histone Deacetylase SIRT6 Inhibits Ovarian Cancer Cell Proliferation Via Down-Regulation of Notch 3 Expression.

SIRT2 activity is required for the survival of C6 glioma cells.

Sirt3 enhances glioma cell viability by stabilizing Ku70-BAX interaction

Effects of SIRT1 Silencing on Viability, Invasion and Metastasis of Human Glioma Cell Lines

Targeting Interleukin 6 Signaling Suppresses Glioma Stem Cell Survival and Tumor Growth.

Sirtuin1 activator SRT2183 suppresses glioma cell growth involving activation of endoplasmic reticulum stress pathway

Inhibition of Notch Signaling Blocks Growth of Glioblastoma Cell Lines and Tumor Neurospheres.

Transcriptional Activation of SIRT6 Via FKHRL1/FOXO3a Inhibits the Warburg Effect in Glioblastoma Cells.

Sirtuin 7 Promotes Glioma Proliferation and Invasion Through Activation of the ERK/STAT3 Signaling Pathway.

Histone deacetylase 6 promotes growth of glioblastoma through inhibition of SMAD2 signaling

GSK-3 beta regulates tumor growth and angiogenesis in human glioma cells

HDAC6 inhibition induces glioma stem cells differentiation and enhances cellular radiation sensitivity through the SHH/Gli1 signaling pathway.

Inhibition of EGR1 Inhibits Glioma Proliferation by Targeting CCND1 Promoter

Knockdown of STAT3 Expression by RNAi Suppresses Growth and Induces Apoptosis and Differentiation in Glioblastoma Stem Cells.

Silent information regulator 3 modulates lysosome function to inhibit apoptosis of U87 cell by mTOR pathway